The analyzed polymorphisms belonging to a wide variety of genes, e.g., SOD, PON, GPx, GST, TXN, CAT, ALOX12, GSR, and NOS, focused on BMD variation, which is the current clinical gold standard for analyzing reductions in bone mass and diagnosing osteoporosis. This evidence concerns the gene CAT and osteoporosis.